Rosiglitazone in Diabetic Patients With Heart Failure - Rosiglitazone in Diabetic Patients With Heart Failure

Description:

The goal of the trial was to evaluate the effect of rosiglitazone on left ventricular ejection fraction (LVEF) among patients with type 2 diabetes and pre-existing chronic heart failure (CHF).